Iron-deficiency Clinical Trials

9 recruiting

Frequently Asked Questions

Common questions about Iron-deficiency clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 110 of 10 trials

Recruiting
Phase 4

Impact of Intravenous Iron Repletion On Mechanisms of Exercise InTolerance in HFpEF (IRONMET-HFpEF)

Iron-deficiencyHeart Failure With Preserved Ejection Fraction
Massachusetts General Hospital66 enrolled1 locationNCT04945707
Recruiting
Phase 4

The Impact of IV Iron on Exercise Capacity and Quality of Life in Pulmonary Hypertension

Pulmonary HypertensionIron-deficiency
Ziekenhuis Oost-Limburg306 enrolled7 locationsNCT07359599
Recruiting
Phase 1

The Effect of an Oral Nutritional Supplement on the Nutritional and Health Outcomes of the Elderly

Body WeightHypertensionIron-deficiency+4 more
University of Ghana80 enrolled1 locationNCT06773975
Recruiting
Phase 4

Effect of Oral sucRosomIal Iron on exerciSE Capacity and Quality of Life in Patients With Heart Failure

Iron-deficiencyChronic Heart FailureLeft Ventricular Systolic Dysfunction
Raffaele De Caterina60 enrolled1 locationNCT06270498
Recruiting

PEPPI Study: Identification of Women at Risk for Placental Dysfunction

Cardiovascular DiseasesPolycystic Ovary SyndromePre-Eclampsia+4 more
Oulu University Hospital3,000 enrolled1 locationNCT06115122
Recruiting

Non-invasive Detection of Iron Deficiency in Obstetrics

Iron-deficiencyPostpartum DepressionIron Deficiency Anemia of Pregnancy+5 more
Wuerzburg University Hospital500 enrolled1 locationNCT07083492
Recruiting
Phase 4

IRONICA: IRON Repletion In Heart Failure - A Comparison of Oral and IV Approaches

Heart FailureHeart Failure With Preserved Ejection Fraction (HFpEF)Heart Failure With Reduced Ejection Fraction (HFrEF)+2 more
Syed Hamza Mufarrih250 enrolled1 locationNCT07053475
Recruiting
Phase 4

The Effects of Low-Dose Versus High-Dose Intravenous IRON Therapy With Ferric DerisomaltOSE in Patients With Chronic Heart Failure and Iron Deficiency

Heart FailureIron-deficiency
China-Japan Friendship Hospital114 enrolled1 locationNCT06427343
Recruiting

Impact of Iron Deficiency Anemia on Neurobehavioral and Cognitive Development in Children Aged 6 to 24 Months

Iron-Deficiency AnemiaNeurobehavioral ManifestationsGrowth Disorders+1 more
Pingshan District Maternal & Child Healthcare Hospital of Shenzhen1,000 enrolled1 locationNCT06662045
Recruiting
Phase 2

Iron Isomaltide for Iron-deficiency Anemia Patients With Locally Advanced Nasopharyngeal Carcinoma

Nasopharyngeal CarcinomaAnemiaIron-deficiency
Sun Yat-sen University120 enrolled1 locationNCT05913414